المؤلفون: Michael Weichenthal, Patrick Terheyden, Edgar Dippel, Georg Lodde, Rudolf A. Herbst, Inga Möller, Lisa Zimmer, Dirk Schadendorf, Julia Kretz, Peter Mohr, Ralf Gutzmer, Jochen Utikal, Eleftheria Chorti, Johanna Matull, Claudia Pföhler, Annette Paschen, Luisa Richter, Anne Zaremba, Philipp Jansen, Friedegund Meier, Selma Ugurel, Carl M. Thielmann, Antje Sucker, Eva Hadaschik, Jens Ulrich, Klaus G. Griewank, Alexander Kreuter, Rajmohan Murali, Elisabeth Livingstone

المصدر: Eur J Cancer

مصطلحات موضوعية: Adult, Male, Neuroblastoma RAS viral oncogene homolog, congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, Skin Neoplasms, Adolescent, Immune checkpoint inhibitors, Medizin, Gene mutation, medicine.disease_cause, Article, Young Adult, Humans, Medicine, Immune Checkpoint Inhibitors, Melanoma, neoplasms, Gene, Aged, Aged, 80 and over, Mutation, Neurofibromin 1, business.industry, Middle Aged, medicine.disease, Immune checkpoint, nervous system diseases, Oncology, Cohort, Cancer research, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55018505c8924b71ce959451efd5e004Test
https://doi.org/10.1016/j.ejca.2021.09.035Test

المؤلفون: Christian U. Blank, Michele Maio, Michael A. Postow, Benjamin Weide, Phillip Wong, Dirk Schadendorf, Anna Maria Di Giacomo, Florian Heubach, Jianda Yuan, Paolo A. Ascierto, Amir Khammari, Marnix H Geukes Foppen, Brigitte Dréno, Graham Pawelec, Claus Garbe, Emanuela Romano, Domenico Mallardo, Bastian Schilling, Jedd D. Wolchok, Kilian Wistuba-Hamprecht, Alexander Martens

المساهمون: Department of Dermatology [Tubingen, Germany], University Medical Center [Tubingen, Germany], Department of Internal Medicine II [Tübingen, Germany], University Medical Center [Tübingen, Germany], Immunité et cancer (U932), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), The Netherlands Cancer Institute [Amsterdam, The Netherlands], Memorial Sloane Kettering Cancer Center [New York], Weill Medical College of Cornell University [New York], Istituto Nazionale Tumori Fondazione Pascale [Naples, Italy], Department of Dermatology [Essen, Germany], University Hospital [Essen, Germany]-West German Cancer Center [Essen, Germany]-University Duisburg-Essen [Germany], German Cancer Consortium [Heidelberg] (DKTK), Division of Medical Oncology and Immunotherapy [Siena, Italy], University Hospital of Siena, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), School of Science and Technology [Nottingham, U.K.], Nottingham Trent University, Division of Cancer Studies [London, UK], King‘s College London, Parts of this study were funded by Bristol-Myers Squibb (Munich, Germany) to B Weide. Parts of this study were funded by the EU Seventh Framework Program ‘PRIAT’ (Profiling Responders In Antibody Therapies) grant agreement no 305309 to C Garbe. Parts of this study were funded by Deutsche Forschungsgemeinschaft DFG PA 361-22/1 to G. Pawelec., European Project: 305309,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,PRIAT(2012), Bernardo, Elizabeth, Profiling Responders In Antibody Therapies - PRIAT - - EC:FP7:HEALTH2012-11-01 - 2014-10-31 - 305309 - VALID, Immunité et cancer ( U932 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut Curie-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Memorial Sloan Kettering Cancer Center [New York, NY, USA], Weill Cornell Medical College [New York, NY, USA], German Cancer Consortium - DKTK [Heidelberg, Germany], Centre de Recherche en Cancérologie / Nantes - Angers ( CRCNA ), CHU Angers-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Hôpital Laennec-Centre National de la Recherche Scientifique ( CNRS ) -Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes ( CHU Nantes ), Nottingham Trent University [U.K.], European Project : 305309,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,PRIAT ( 2012 ), Universität Duisburg-Essen = University of Duisburg-Essen [Essen]-University Hospital [Essen, Germany]-West German Cancer Center [Essen, Germany]

المصدر: European Journal of Cancer
European Journal of Cancer, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. 〈10.1016/j.ejca.2016.12.011〉
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩

مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Programmed Cell Death 1 Receptor, Medizin, Kaplan-Meier Estimate, CD8-Positive T-Lymphocytes, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, 0302 clinical medicine, Biomarker, Effector memory cells, Ipilimumab, Melanoma, Prognosis, medicine.diagnostic_test, Effector, Antibodies, Monoclonal, Middle Aged, Flow Cytometry, Peripheral, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Peripheral blood mononuclear cell, Article, Flow cytometry, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Antigens, Neoplasm, Internal medicine, Biomarkers, Tumor, medicine, Humans, Aged, business.industry, medicine.disease, 030104 developmental biology, Immunology, business, Immunologic Memory, CD8

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a6982f18635313131b596d20ee2f8dTest
https://doi.org/10.1016/j.ejca.2016.12.011Test

المؤلفون: Celia Requena, Eduardo Nagore, Zaida García-Casado, Rajesh Kumar, Ruth M. Pfeiffer, Maria Teresa Landi, Pablo Espinosa

المصدر: European Journal of Cancer. 53:115-124

مصطلحات موضوعية: Adult, Keratinocytes, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Adolescent, Genotype, Population, Sunburn, Article, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, Cumulative incidence, Basal cell carcinoma, Sex Distribution, Hair Color, education, Melanoma, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Proportional hazards model, Smoking, Neoplasms, Second Primary, Retrospective cohort study, Middle Aged, medicine.disease, Carcinoma, Basal Cell, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Skin cancer, business, Receptor, Melanocortin, Type 1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c1911d4cfc2bcc7f82a6cb5febb3b0Test
https://doi.org/10.1016/j.ejca.2015.10.058Test

المؤلفون: C. F. Shelton, E. G. Chiorean, Donald L. Durden, Stephen P. Anthony, A. Stejskal-Barnett, Daruka Mahadevan, F. Cordova, Wenqing Qi, Joseph R. Garlich, M. D. Becker, Ramesh K. Ramanathan, Wayne Harris, D. M. Rensvold, D. D. Von Hoff, A. E. Younger

المصدر: European Journal of Cancer. 48:3319-3327

مصطلحات موضوعية: Adult, Male, Drug, Cancer Research, Maximum Tolerated Dose, Gastrointestinal Diseases, media_common.quotation_subject, Salvage therapy, Antineoplastic Agents, Hypokalemia, Mechanistic Target of Rapamycin Complex 1, Pharmacology, Biology, Article, Young Adult, Pharmacokinetics, Neoplasms, medicine, Humans, Prodrugs, Molecular Targeted Therapy, Infusions, Intravenous, Protein Kinase Inhibitors, B cell, Aged, Phosphoinositide-3 Kinase Inhibitors, media_common, Aged, 80 and over, Salvage Therapy, Dose-Response Relationship, Drug, TOR Serine-Threonine Kinases, Proteins, Middle Aged, Prodrug, medicine.disease, Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm Proteins, Lymphoma, Leukemia, medicine.anatomical_structure, Oncology, Chromones, Multiprotein Complexes, Pharmacodynamics, Female, Lymphoma, Large B-Cell, Diffuse, Oligopeptides

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1122ebca542d2c3e2bed39e5819823eTest
https://doi.org/10.1016/j.ejca.2012.06.027Test

المؤلفون: Jeffrey E. Gershenwald, Li E. Wang, Qingyi Wei, Victor G. Prieto, Yu Jing Huang, Elizabeth A. Grimm, Jeffrey E. Lee, Ming Yin, Madeleine Duvic

المصدر: European Journal of Cancer. 47:107-115

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Linkage disequilibrium, Skin Neoplasms, Genotype, Biology, Polymorphism, Single Nucleotide, Gastroenterology, Article, Young Adult, Risk Factors, Polymorphism (computer science), Internal medicine, Genetic variation, Genetic predisposition, medicine, Humans, Genetic Predisposition to Disease, Melanoma, Aged, Genetics, Haplotype, Case-control study, Odds ratio, Middle Aged, Oncology, Case-Control Studies, Female, Matrix Metalloproteinase 1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bab4fc5ce717c38d20201c82b1a1070Test
https://doi.org/10.1016/j.ejca.2010.06.129Test

المؤلفون: Dirix, L. Y., Tonnesen, F., Cassidy, J., Epelbaum, R., Huinink, W. W. Ten Bokkel, Pavlidis, Nicholas, Sorio, R., Gamucci, T., Wolff, I., Velde, A. Te, Lan, J., Verweij, J.

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

المصدر: European journal of cancer
European Journal of Cancer Part A

مصطلحات موضوعية: Male, Cancer Research, Indoles, Pancreatic disease, Colorectal cancer, medicine.medical_treatment, Aziridines, Phases of clinical research, Digestive System Neoplasms, Gastroenterology, Antineoplastic Agents/*adverse effects/therapeutic use, Breast cancer, Pancreatic Neoplasms/drug therapy, Antineoplastic agents, 80 and over, Indoles/*adverse effects/therapeutic use, Middle aged, Pancreas cancer, Priority journal, 5 (1 aziridinyl) 3 hydroxymethyl 2 (3 hydroxy 1 propenyl) 1 methyl 4, Aged, 80 and over, Eo9, Breast Neoplasms/*drug therapy, Colorectal Neoplasms/drug therapy, Nausea, Middle Aged, Multicenter study, Digestive System Neoplasms/*drug therapy, Clinical trial, Indolequinones, Proteinuria, medicine.anatomical_structure, Oncology, Female, Colorectal Neoplasms, Pancreas, Human, Adult, medicine.medical_specialty, Pancreatic neoplasms, Vomiting, Stomach cancer, Stomach neoplasms, Aziridines/*adverse effects/therapeutic use, Antineoplastic Agents, Breast Neoplasms, Major clinical study, Follow-up studies, Article, Colorectal neoplasms, Proteinuria/chemically induced, Stomach Neoplasms, Pancreatic cancer, Internal medicine, medicine, Humans, Phase 2 clinical trial, Aged, Antineoplastic activity, Chemotherapy, business.industry, 7 indoledione, Phase ii study, Cancer, medicine.disease, Pancreatic Neoplasms, Digestive system neoplasms, Renal toxicity, Stomach Neoplasms/drug therapy, Intravenous drug administration, Human medicine, Breast neoplasms, Gastric cancer, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63e22d5b3f7daefd9445b39d685d20fTest
https://doi.org/10.1016/0959-8049Test(96)00226-2

المؤلفون: Thomas, A. L., Cox, G., Sharma, R. A., Steward, W. P., Shields, F., Jeyapalan, K., Muller, S., O'Byrne, Kenneth J.

المصدر: European Journal of Cancer

مصطلحات موضوعية: Gemcitabine, Non-small cell lung cancer, Paclitaxel, Pneumonitis, prednisolone, adult, aged, antineoplastic activity, article, cancer staging, cancer survival, clinical article, clinical trial, dose response, drug efficacy, female, human, lung non small cell cancer, male, phase 1 clinical trial, phase 2 clinical trial, pneumonia, priority journal, treatment outcome, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cohort Studies, Deoxycytidine, Dose-Response Relationship

العلاقة: Thomas, A. L., Cox, G., Sharma, R. A., Steward, W. P., Shields, F., Jeyapalan, K., Muller, S., & O'Byrne, Kenneth J. (2000) Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer : report of a phase I/II dose-escalating study. European Journal of Cancer, 36(18), pp. 2329-2334.; https://eprints.qut.edu.au/65775Test/; Faculty of Health; Institute of Health and Biomedical Innovation

الإتاحة: https://doi.org/10.1016/S0959-8049Test(00)00341-5
https://eprints.qut.edu.au/65775Test/